To the best of our knowledge, our study was the first to demonstrate that MYOSLID as a prognostic CSRL for colon cancer, and that knockdown of MYOSLID inhibited CS and growth of colon cancer. The gene discussed is MYOSLID; the disease is colonic neoplasm.